Biomerica offers new coeliac disease test:

Biomerica's diagnostics division is adding GliaQuant IgG to monitor gliadin, a protein that causes coeliac disease. Coeliac disease is an inherited autoimmune response of the gastrointestinal tract to traces of gliadin in the gluten of wheat, barley, rye and oats. The disease could affect as many as one in 250 Americans, although fewer than one in 4,700 of the US population has been diagnosed. The product joins a rapidly increasing range of gastrointestinal diagnostic products, including H Pylori and a food allergens kit. The Newport Beach, California-based company says that it will introduce one more digestive disease product in the next few months. The GliaQuant test is available outside the US.